These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Activation of latent transforming growth factor beta1 by stromelysin 1 in extracts of growth plate chondrocyte-derived matrix vesicles. Maeda S; Dean DD; Gay I; Schwartz Z; Boyan BD J Bone Miner Res; 2001 Jul; 16(7):1281-90. PubMed ID: 11450704 [TBL] [Abstract][Full Text] [Related]
3. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3). Maeda S; Dean DD; Gomez R; Schwartz Z; Boyan BD Calcif Tissue Int; 2002 Jan; 70(1):54-65. PubMed ID: 11907708 [TBL] [Abstract][Full Text] [Related]
4. Vitamin D3 metabolites regulate LTBP1 and latent TGF-beta1 expression and latent TGF-beta1 incorporation in the extracellular matrix of chondrocytes. Pedrozo HA; Schwartz Z; Mokeyev T; Ornoy A; Xin-Sheng W; Bonewald LF; Dean DD; Boyan BD J Cell Biochem; 1999 Jan; 72(1):151-65. PubMed ID: 10025676 [TBL] [Abstract][Full Text] [Related]
5. 1alpha,25(OH)2D3 causes a rapid increase in phosphatidylinositol-specific PLC-beta activity via phospholipase A2-dependent production of lysophospholipid. Schwartz Z; Shaked D; Hardin RR; Gruwell S; Dean DD; Sylvia VL; Boyan BD Steroids; 2003 May; 68(5):423-37. PubMed ID: 12798493 [TBL] [Abstract][Full Text] [Related]
6. Potential mechanisms for the plasmin-mediated release and activation of latent transforming growth factor-beta1 from the extracellular matrix of growth plate chondrocytes. Pedrozo HA; Schwartz Z; Robinson M; Gomes R; Dean DD; Bonewald LF; Boyan BD Endocrinology; 1999 Dec; 140(12):5806-16. PubMed ID: 10579347 [TBL] [Abstract][Full Text] [Related]
7. Direct effects of transforming growth factor-beta on chondrocytes are modulated by vitamin D metabolites in a cell maturation-specific manner. Schwartz Z; Bonewald LF; Caulfield K; Brooks B; Boyan BD Endocrinology; 1993 Apr; 132(4):1544-52. PubMed ID: 8462452 [TBL] [Abstract][Full Text] [Related]
8. 1,25-Dihydroxy vitamin D3 is an autocrine regulator of extracellular matrix turnover and growth factor release via ERp60-activated matrix vesicle matrix metalloproteinases. Boyan BD; Schwartz Z Cells Tissues Organs; 2009; 189(1-4):70-4. PubMed ID: 18765931 [TBL] [Abstract][Full Text] [Related]
9. Phospholipase A2 activating protein (PLAA) is required for 1alpha,25(OH)2D3 signaling in growth plate chondrocytes. Schwartz Z; Graham EJ; Wang L; Lossdörfer S; Gay I; Johnson-Pais TL; Carnes DL; Sylvia VL; Boyan BD J Cell Physiol; 2005 Apr; 203(1):54-70. PubMed ID: 15368540 [TBL] [Abstract][Full Text] [Related]
11. 1alpha,25(OH)2D3 is an autocrine regulator of extracellular matrix turnover and growth factor release via ERp60 activated matrix vesicle metalloproteinases. Boyan BD; Wong KL; Fang M; Schwartz Z J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):467-72. PubMed ID: 17224270 [TBL] [Abstract][Full Text] [Related]
12. Latent transforming growth factor-beta is produced by chondrocytes and activated by extracellular matrix vesicles upon exposure to 1,25-(OH)2D3. Boyan BD; Schwartz Z; Park-Snyder S; Dean DD; Yang F; Twardzik D; Bonewald LF J Biol Chem; 1994 Nov; 269(45):28374-81. PubMed ID: 7961777 [TBL] [Abstract][Full Text] [Related]
13. Direct effects of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on growth zone and resting zone chondrocyte membrane alkaline phosphatase and phospholipase-A2 specific activities. Schwartz Z; Schlader DL; Swain LD; Boyan BD Endocrinology; 1988 Dec; 123(6):2878-84. PubMed ID: 3264240 [TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone and transforming growth factor-beta1 coregulate chondrocyte differentiation in vitro. Nasatzky E; Azran E; Dean DD; Boyan BD; Schwartz Z Endocrine; 2000 Dec; 13(3):305-13. PubMed ID: 11216642 [TBL] [Abstract][Full Text] [Related]
15. Stathmin levels in growth plate chondrocytes are modulated by vitamin D3 metabolites and transforming growth factor-beta1 and are associated with proliferation. Hummert TW; Schwartz Z; Sylvia VL; Dean DD; Boyan BD Endocrine; 2001 Jun; 15(1):93-101. PubMed ID: 11572331 [TBL] [Abstract][Full Text] [Related]
16. Recombinant bone morphogenetic protein (BMP)-2 regulates costochondral growth plate chondrocytes and induces expression of BMP-2 and BMP-4 in a cell maturation-dependent manner. Erickson DM; Harris SE; Dean DD; Harris MA; Wozney JM; Boyan BD; Schwartz Z J Orthop Res; 1997 May; 15(3):371-80. PubMed ID: 9246083 [TBL] [Abstract][Full Text] [Related]
17. Vitamin D metabolites regulate matrix vesicle metalloproteinase content in a cell maturation-dependent manner. Dean DD; Boyan BD; Muniz OE; Howell DS; Schwartz Z Calcif Tissue Int; 1996 Aug; 59(2):109-16. PubMed ID: 8687979 [TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta1 regulation of growth zone chondrocytes is mediated by multiple interacting pathways. Rosado E; Schwartz Z; Sylvia VL; Dean DD; Boyan BD Biochim Biophys Acta; 2002 Jun; 1590(1-3):1-15. PubMed ID: 12063164 [TBL] [Abstract][Full Text] [Related]
19. Membrane actions of vitamin D metabolites 1alpha,25(OH)2D3 and 24R,25(OH)2D3 are retained in growth plate cartilage cells from vitamin D receptor knockout mice. Boyan BD; Sylvia VL; McKinney N; Schwartz Z J Cell Biochem; 2003 Dec; 90(6):1207-23. PubMed ID: 14635194 [TBL] [Abstract][Full Text] [Related]
20. TGFbeta1 regulates 25-hydroxyvitamin D3 1alpha- and 24-hydroxylase activity in cultured growth plate chondrocytes in a maturation-dependent manner. Pedrozo HA; Boyan BD; Mazock J; Dean DD; Gomez R; Schwartz Z Calcif Tissue Int; 1999 Jan; 64(1):50-6. PubMed ID: 9868284 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]